時代鄰里(09928.HK)獲控股股東卓源增持90萬股
格隆匯5月17日丨時代鄰里(09928.HK)公佈,公司董事會獲公司控股股東卓源創投有限公司("卓源")吿知,於2021年5月12日至2021年5月14日期間,卓源於公開市場以每股股份平均價格約5.07港元收購總計90萬股公司股份。
董事會認為,卓源增持股份充分顯示彼對公司作出的長期承諾以及對公司的整體發展前景及增長潛力充滿信心。緊隨收購後,卓源於462,693,077股股份中擁有權益,佔於公吿日期公司已發行股本總數約46.94%。
如卓源所吿知,彼對本公司未來前景和長期發展充滿信心,不排除於時機恰當時在適用法律及法規的規限下進一步增持本公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.